SHELTON CAPITAL MANAGEMENT - PLURISTEM THERAPEUTICS INC ownership

PLURISTEM THERAPEUTICS INC's ticker is PSTI and the CUSIP is 72940R300. A total of 49 filers reported holding PLURISTEM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.99 and the average weighting 0.0%.

Quarter-by-quarter ownership
SHELTON CAPITAL MANAGEMENT ownership history of PLURISTEM THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$158,000
-40.6%
128,5320.0%0.01%
-30.0%
Q1 2022$266,000
-24.0%
128,532
-46.4%
0.01%
-16.7%
Q4 2021$350,000
-45.0%
240,0000.0%0.01%
-52.0%
Q3 2021$636,000
-27.0%
240,000
+9.1%
0.02%
-24.2%
Q2 2021$871,000
-17.0%
220,0000.0%0.03%
-10.8%
Q1 2021$1,049,000220,0000.04%
Other shareholders
PLURISTEM THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Values First Advisors, Inc. 44,549$394,0000.39%
ARK Investment Management 1,168,616$10,331,0000.11%
MEITAV INVESTMENT HOUSE LTD 136,769$1,209,0000.07%
SABBY MANAGEMENT, LLC 29,699$263,0000.05%
ALGERT GLOBAL LLC 15,620$138,0000.05%
Shepherd Financial Partners LLC 16,730$148,0000.04%
Savior LLC 3,393$30,0000.04%
Lehman & Derafelo Financial Resources LLC 10,000$88,0000.03%
FORA Capital, LLC 8,800$78,000,0000.03%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 44,470$393,0000.02%
View complete list of PLURISTEM THERAPEUTICS INC shareholders